Global Coalition for Adaptive Research

Lexington, United States Founded: 2017 • Age: 9 yrs
Nonprofit organization sponsors clinical trials for rare diseases worldwide.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 21 Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About Global Coalition for Adaptive Research

Global Coalition for Adaptive Research is a company based in Lexington (United States) founded in 2017. It operates as a B2B and Non-profit Collaboration. The company has 21 employees as of December 31, 2022. Global Coalition for Adaptive Research offers products and services including GBM AGILE, REMAP-CAP, and Ovarian CanceRx. Global Coalition for Adaptive Research operates in a competitive market with competitors including Vial, Javara Research, Alcanza Clinical Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.

  • Headquarter Lexington, United States
  • Employees 21 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Global Coalition For Adaptive Research (Gcar)
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Education, Research & Associations
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    21

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Global Coalition for Adaptive Research

Global Coalition for Adaptive Research offers a comprehensive portfolio of products and services, including GBM AGILE, REMAP-CAP, and Ovarian CanceRx.

Primary

Adaptive trial evaluating treatments for glioblastoma.

Platform trial for COVID-19 treatments and responses.

Trial focused on ovarian cancer therapies development.

People of Global Coalition for Adaptive Research

Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Jennifer Smith
Senior Accounting Associate
People
Rachael Coleman
CFO And COO
People
Matthew Viva
Director, Legal
People
Rachel Rosenstein-Sisson
Senior Director, Communications / Learning & Development

Unlock access to complete

Funding Insights of Global Coalition for Adaptive Research

Investments & Acquisitions by Global Coalition for Adaptive Research

Investments

Financial Statements - Global Coalition for Adaptive Research

Global Coalition For Adaptive Research Comparisons

+
Add Comparison
Available on Premium

Competitors of Global Coalition for Adaptive Research

Global Coalition for Adaptive Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vial, Javara Research, Alcanza Clinical Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Healthcare data capture, clinical trials, and CRO services are provided.
domain founded_year HQ Location
Clinical trials for pharmaceuticals are conducted across therapeutic areas.
domain founded_year HQ Location
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
domain founded_year HQ Location
Clinical research unit for phase I, II and III trials
domain founded_year HQ Location
Early-phase oncology clinical trials and research services are provided.

Latest news on Global Coalition For Adaptive Research

Frequently Asked Questions about Global Coalition for Adaptive Research

Global Coalition for Adaptive Research was founded in 2017.

Global Coalition for Adaptive Research is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

As of Dec 31, 2022, the latest employee count at Global Coalition for Adaptive Research is 21.

Global Coalition for Adaptive Research is a nonprofit that develops and sponsors master protocols and adaptive platform trials to accelerate treatment discovery for rare and deadly diseases. It collaborates with investigators and partners to design innovative trials for conditions like glioblastoma and COVID-19. Based in Larkspur, California, USA, GCAR focuses on efficient, seamless research to improve patient outcomes through international trial sites and scientific expertise.

Global Coalition for Adaptive Research's top competitors include Javara Research, Vial and The START Center for Cancer Research.

Global Coalition for Adaptive Research offers GBM AGILE, REMAP-CAP, and Ovarian CanceRx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available